Skip to main content

Together we are beating cancer

Donate now

For Researchers

Showing 12 out of 337 results
Careers

Clinical academics hold a vital place in the cancer research landscape; so why is it proving so hard to retain them, and what can we do about it? Clinical academics hold a vital place in the cancer research landscape; so why is it proving so hard to retain them, and what can we do about it?

by Cancer Research UK | Analysis | 14 October 2025

14 October 2025

This entry is part 7 of 7 in the series Research Careers
ageing

Cancer incidence increases with ageing – except in the very old, where rates of the disease drop. Why is that? Cancer incidence increases with ageing – except in the very old, where rates of the disease drop. Why is that?

by Cancer Research UK | In depth | 8 October 2025

8 October 2025

Diversity,And,Inclusion.,Multi,Colored,Puzzle,With,Figures,Of,People

The issue of cancer inequality is layered, with differences in outcome at each stage of the cancer journey. But researchers are doing the work to put together the pieces of the puzzle… The issue of cancer inequality is layered, with differences in outcome at each stage of the cancer journey. But researchers are doing the work to put together the pieces of the puzzle…

by Cancer Research UK | In depth | 2 October 2025

2 October 2025

International clinical trials

International trials are vital to children’s and young people’s cancer research but can be notoriously difficult to set up. We get into the challenges… International trials are vital to children’s and young people’s cancer research but can be notoriously difficult to set up. We get into the challenges…

by Cancer Research UK | In depth | 24 September 2025

24 September 2025

BAL
  • For Researchers

A bridge for your career

Making the leap to form and lead your own lab can daunting – which is why CRUK created the Bridge to Academic Leadership (BAL) programme. Making the leap to form and lead your own lab can daunting – which is why CRUK created the Bridge to Academic Leadership (BAL) programme.

by Cancer Research UK | In depth | 17 September 2025

17 September 2025

Illustration of epigenetic light switch

Checkpoint inhibitors have utterly changed the immunotherapy landscape – but there could be a different kind of checkpoint just waiting to be targeted... Checkpoint inhibitors have utterly changed the immunotherapy landscape – but there could be a different kind of checkpoint just waiting to be targeted...

by Cancer Research UK | In depth | 11 September 2025

11 September 2025

ageing

The transition from normal to pre-cancerous tissue remains underexplored. Ageing research, by contrast, has long studied normal tissue decline... The transition from normal to pre-cancerous tissue remains underexplored. Ageing research, by contrast, has long studied normal tissue decline...

by Cancer Research UK | Analysis | 27 August 2025

27 August 2025

Linda Wooldridge

Linda Wooldridge talks cancer vaccines, minor histocompatibility antigens and even how to bounce back if your funding application is rejected…   Linda Wooldridge talks cancer vaccines, minor histocompatibility antigens and even how to bounce back if your funding application is rejected…  

by Phil Prime | Interview | 29 July 2025

29 July 2025

This entry is part 16 of 16 in the series Research Integrity
Ribosomes

Once thought too conserved to be a therapeutic target for cancer, new insights could reveal ribosomal biogenesis to be an Achilles heel... Once thought too conserved to be a therapeutic target for cancer, new insights could reveal ribosomal biogenesis to be an Achilles heel...

by Cancer Research UK | In depth | 9 July 2025

9 July 2025

This entry is part 6 of 7 in the series Research Careers